Trial
NCT01386372
Tolvaptan for In-hospital Hyponatremia
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Mario Negri Institute for Pharmacological Research
Collaborators
A.O. Ospedale Papa Giovanni XXIII
Condition
Hyponatremia
Intervention
Tolvaptan
Why stopped
futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-12-15